中国麻风皮肤病杂志 ›› 2023, Vol. 39 ›› Issue (3): 212-217.doi: 10.12144/zgmfskin202303212

• 综述 • 上一篇    下一篇

PD-1/PD-L1抑制剂治疗皮肤恶性肿瘤研究进展

陈琦,仰珈仪,王秀丽   

  1. 同济大学附属皮肤病医院/上海市皮肤病医院，光医学研究所，上海，200092
  • 出版日期:2023-03-15 发布日期:2023-02-16

Update of PD-1/PD-L1 inhibitors in the treatment of skin malignant cancer

CHEN Qi, YANG Jiayi, WANG Xiuli   

  1. Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China
  • Online:2023-03-15 Published:2023-02-16

PDF (PC)

140

摘要： 近年来免疫检查点抑制剂程序性细胞死亡蛋白1及其配体1（PD-1/PD-L1）是皮肤恶性肿瘤治疗的重要靶点。本文就PD-1/PD-L1抑制剂在治疗皮肤恶性肿瘤的研究进展作一综述。

关键词: 皮肤恶性肿瘤, 免疫检查点抑制剂, PD-1/PD-L1

Abstract: Immune checkpoint inhibitor programmed cell death protein 1 and its ligand 1 (PD-1/PD-L1) are important targets of the treatment for skin cancer in recent years. The update of PD-1/PD-L1 inhibitors in the treatment of skin malignant cancer is reviewed in this paper.

Key words: skin cancer, immune checkpoint inhibitor, PD-1/PD-L1